GL1X · GenesisL1 explorer

MolNFT v2 · #113146 · protein

Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2

MolNFT v2 record #113146 on GenesisL1: PDB 4ZYI, “Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt…”. Protein, 96 residues. 3D structure, sequence proof, BLAST and…

PDB
4ZYI
Type
protein
Length
96 residues
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.